S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
LON:BXP

Beximco Pharmaceuticals (BXP) Share Forecast, Price & News

GBX 38.50
0.00 (0.00%)
(As of 10/2/2023 09:00 PM ET)
Compare
Today's Range
38.50
38.50
50-Day Range
35.50
43
52-Week Range
33.30
71.50
Volume
13,000 shs
Average Volume
68,253 shs
Market Capitalization
£171.75 million
P/E Ratio
550.00
Dividend Yield
7.79%
Price Target
N/A

BXP stock logo

About Beximco Pharmaceuticals (LON:BXP) Stock

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

BXP Price History

BXP Stock News Headlines

BXP.L - Beximco Pharmaceuticals Limited
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Beximco Pharmaceuticals
Beximco Pharmaceuticals Ltd.
Beximco Pharmaceuticals Ltd (BXPH)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Beximco Pharmaceuticals Ltd. GDR
Beximco Pharma Share Chat
Beximco Pharmaceut - Price Monitoring Extension
Beximco Pharma Share News (BXP)
Sanofi selects Beximco as potential buyer
See More Headlines
Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
£171.75 million
Optionable
Optionable
Beta
0.70
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Md. Nazmul Hassan MP
    MD & Director
  • Mr. Mohammad Ali Nawaz
    Chief Financial Officer
  • Mr. S. M. Rabbur Reza
    Chief Operating Officer
  • Mr. Jamal Ahmed Choudhury
    Director of Accounts & Fin.
  • Mr. Rizvi Ul Kabir
    Director of Marketing
  • Mr. M. A. Arshad Bhuiyan
    Gen. Mang. of HR
  • Mr. Zakaria Seraj Chowdhury
    Head of Distribution Services & Director of International Marketing
  • Mr. Mohammad Asad Ullah FCS
    Company Sec. & Exec. Director













BXP Stock - Frequently Asked Questions

How have BXP shares performed in 2023?

Beximco Pharmaceuticals' stock was trading at GBX 54 on January 1st, 2023. Since then, BXP stock has decreased by 28.7% and is now trading at GBX 38.50.
View the best growth stocks for 2023 here
.

Is Beximco Pharmaceuticals a good dividend stock?

Beximco Pharmaceuticals (LON:BXP) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 7.05%. BXP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,285.71%. Payout ratios above 75% are not desirable because they may not be sustainable.

What is Beximco Pharmaceuticals' stock symbol?

Beximco Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "BXP."

How do I buy shares of Beximco Pharmaceuticals?

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Beximco Pharmaceuticals' stock price today?

One share of BXP stock can currently be purchased for approximately GBX 38.50.

How much money does Beximco Pharmaceuticals make?

Beximco Pharmaceuticals (LON:BXP) has a market capitalization of £171.75 million.

How many employees does Beximco Pharmaceuticals have?

The company employs 5,500 workers across the globe.

How can I contact Beximco Pharmaceuticals?

Beximco Pharmaceuticals' mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The official website for the company is www.beximco-pharma.com. The company can be reached via phone at +880-2-58611001.

This page (LON:BXP) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -